YD Bio Ltd (YDES) Stock Price & Analysis
YD Bio Ltd (YDES) closed at USD 6.74 on Thursday, October 15, 2026, up 5.97% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 6.36; the Oct 15, 2026 session ranged USD 6.31–6.87 on volume of 72,321 shares. Market capitalization is $477.40M, with a 52-week range of USD 1.7–22 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/YDES.md
Key facts (YDES)
- Analysts: None.
- Total return with dividends: 1Y -64.3% vs S&P 500 +18.1%; 5Y -46.1% vs S&P 500 +85.1%.
Analysts (YDES)
Consensus None.
Total return (dividends reinvested) (YDES)
| 1Y (from 2025-10-16) | 5Y (from 2025-08-25) | |
|---|---|---|
| Total return | -64.3% | -46.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -64.4% | -41.8% |
| Volatility (annualized) | 129.2% | 151.9% |
| Max drawdown | -90.5% (Oct 2025→Jul 2026) | -91.8% (Sep 2025→Jun 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 6.74 |
|---|---|
| Change | ▲ 5.97% (up) |
| Previous Close | USD 6.36 |
| Open | USD 6.34 |
| Day Range | USD 6.31 – 6.87 |
| 52-Week Range | USD 1.7 – 22 |
| Volume | 72,321 shares |
| Market Cap | $477.40M |
| Exchange | NGM |
Technical Analysis (YDES)
Nexqual's technical model rates YDES "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.14 (neutral) |
| vs SMA50 | Above (USD 4.57) |
| MACD | 0.63 (positive) |
Analyst Ratings (YDES)
Wall Street analysts rate YDES "None", per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | None |
|---|
Earnings (YDES)
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (YDES)
| Total Revenue | $1.24M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +314.90% |
| Gross Margin | +29.60% |
| Operating Margin | -382.12% |
| Profit Margin | +24.67% |
| Debt / Equity | 0 |
| Current Ratio | 5.23 |
| Total Cash | $2.66M |
| Total Debt | $5,002 |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (YDES)
Nexqual rates YD Bio Ltd's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Strong — Revenue +315% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $3M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$7M (TTM) |
| Efficiency | Mixed — No data |
Ownership (YDES)
| Insider Ownership | +80.22% |
|---|---|
| Institutional Ownership | +0.40% |
| Shares Outstanding | 70.83M |
| Float | 16.19M |
| Short % of Float | +1.08% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (YDES)
YD Bio Ltd is led by Ethan Shen (age 48), CEO & Chairman, per Nexqual as of October 16, 2026 at 05:21 UTC.
| CEO & Chairman | Ethan Shen (age 48) |
|---|---|
| Chief Financial Officer | Edmund Hen C.P.A., F.C.A., M.S., M.Sc. (age 51) |
| Chief Medical Officer & Director | Benjamin Zhang (age 25) |
Major Backers & Investors (YDES)
Notable institutional backers of YD Bio Ltd include Garrett Wealth Advisory Group, LLC, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Garrett Wealth Advisory Group, LLC | 0.12% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt